SlideShare a Scribd company logo
Regulations for M.Pharm Degree
Academic Year 2015-16
Rajiv Gandhi University of Health Sciences, Karnataka
Presented
By
G.Parthasarathy
Associate Professor and Head,
Department of Pharmaceutics,
R R College of Pharmacy, Bangalore
A Warm Welcome to the fresh students of B.Pharm , Pharm D
and M.Pharm on behalf of The Management, Teaching and Non-
teaching Faculties of RR College of Pharmacy
GOAL of M.Pharm curriculum
To produce a
competent Industrial
Pharmacist.
OBJECTIVE:
• Understanding of the concept and design of various
pharmaceutical dosage forms
• The ability to formulate and evaluate various dosage
forms
• The ability to work independently and as a member of the
team
• The ability to plan his / her work for efficient use of time
and resources
• The ability to identify the cause and to solve the problem
• The ability to think and evaluate scientifically and
critically
Master of Pharmacy (Pharmaceutics)
•Duration of the course
24Months Only
Duration and Course Pattern
The study of M. Pharm course shall be of annual
system, that include
M. Pharm part-I, for twelve months
M. Pharm part-II of twelve months duration.
At the end of M. Pharm part-I, there shall be an
university examination of M. Pharm Part-I.
At the end of M. Pharm Part-II, the candidate shall
submit a dissertation on the topic approved by the
university.
Attendance and Monitoring Process of Studies
• A candidate pursuing M. Pharm course shall study in the concerned
department as full time student.
• Every student shall attend symposia, seminars, conferences, journal review
meetings and lectures during each year as prescribed by the
department/college/university and not absent him/her without valid reasons.
• Candidate who has put in a minimum of 80% of attendance in theory and
practical assignments separately shall be permitted to appear for M. Pharm
part-I examination.
• Candidate who has put in a minimum of 80% of attendance in M.
Pharm part-II shall only be eligible to submit the dissertation.
• Any student who fails to complete the course in the manner stated above shall
not be permitted to appear for the University examinations.
Attendance
80%
compulsory
Monitoring Progress of Studies
• Every candidate shall maintain a work diary and
record of his/her participation in the training
programmes conducted by the department such
as journal reviews, seminars, etc.
• The work diary shall be scrutinized and certified
by the Head of the Department and Head of the
Institution, and presented in the University
practical examination.
• Special circulation may be made to all faculties
about the presentations given by the candidate.
Subjects
(M.Pharm Pharmaceutics)
• Paper I: Modern Pharmaceutical Analysis
• Paper II: Preformulation and Production
Management
• Paper III: Biopharmaceutics and
Pharmacokinetics
• Paper IV: Advances in Drug Delivery Systems
Teaching/ Learning Activities:
 Journal Club: weekly, Journal club meetings to be held to discuss the
recent development in the subject published in the national and
international journals.
 Seminars: Seminars (5-6 in a year) will be arranged from experts in
the field.
 Industrial visits: Visits to pharmaceutical industries to understand
shop floor activities.
 Conferences and meetings: Staff and students will be encouraged to
participate in seminars, workshops and conferences in the area of this
subject.
EXAMINATION
• There shall be an examination for M. Pharm
part-I at the end of on academic year.
• For M. pharm part-II, the examination shall be
an evaluation of dissertation and Viva-Voce at
the end of twelve months (one Year) after
commencement of M. Pharm Part-II course.
SCHEME OF EXAMINATION
• Sessional Examination:
▫ There shall be minimum of two sessional
examinations in each subject
▫ conducted by the colleges for both in theory and
in practical.
▫ The sessional marks shall be awarded out of a
maximum of 50 for theory and practical.
Sessional Examination
Theory Practical
a)
Written
examination
(average of
two)
30 marks a)
Practical
Examination
(average of
two)
30
marks
b) Seminar 20 Marks b) Lab work
20
marks
Total Marks 50 marks Total Marks
50
Marks
Synopsis
• A candidate should submit synopsis of Research
work
• To the Registrar, RGUHS of the intended project
work
• Through the guide, HOD and Head of the
institutions
• Not later than nine months from the date of
admission to M. Pharm part I on or before the
date specified by RGUHS.
Online Registration of Subject for
Synopsis
• All M.Pharm Part-I candidates should register a
topic for their research work in the form of
synopsis in RGUHS format.
• Synopsis should be approved by their Guide,
HOD and Head of the institution before Online
submission.
• Later, A detailed Review report and status of
registration will be communicated to the
students
University Theory Examination
( M. Pharm Part-I)
• There shall be two university examinations
annually conducted at an interval of not less
than four months.
• There shall be four theory papers in the
university examination.
• Each theory paper shall be of 3 hours duration
carrying 100 marks each.
• In each paper, there shall be two long essay
questions of 20 marks
• Five short essay questions of ten marks
• Two short notes of five marks
Theory
Subjects
Duration of
Exam
(Hours)
Maximum
marks for
written exam
Sessional
maximum
marks
Total
Paper I: Modern
Pharmaceutical Analysis
3 100 50 150
Paper II : Preformulation and
Production Management
3 100 50 150
Paper III : Biopharmaceutics
and Pharmacokinetics
3 100 50 150
Paper IV : Advances in Drug
Delivery Systems
3 100 50 150
Total 600
University Practical Exam
( M. Pharm Part-I)
• There shall be four practical examinations in all
subjects.
• The duration of each practical examination is of
six hours
• It will be conducted for 100 marks each.
Practical
Subjects
Duration of
paper
(Hours)
Maximum
marks for
written exam
Sessional
maximum
marks
Total
Paper I: Modern
Pharmaceutical Analysis
6 100 50 150
Paper II : Preformulation and
Production Management
6 100 50 150
Paper III : Biopharmaceutics
and Pharmacokinetics
6 100 50 150
Paper IV : Advances in Drug
Delivery Systems
6 100 50 150
Total 600
Criteria for Pass (M. Pharm Part-I)
• A candidate who secures 50% of marks in each
subject in theory and in practical separately
including sessional marks and university
examination marks together shall be declared to
have passed in M. Pharm part-I examination
• The candidate must secure a minimum of
40% marks (excluding sessionals) in
theory & practical separately.
Minimum
Passing mark
50% (Written +
Sessional IA)
(100+50)
75/150
Written Exam
(Theory/Practical
40% Compulsory
40/100
• Candidate, who fails in theory or practical
exam in a subject, shall appear for
both theory and practical in the
subsequent examination in a subject.
• Candidates permitted to take re-sessional
examination after the announcement of
results only once
M. Pharm. Part -II
Dissertation
• Every candidate pursuing M. Pham
course is required to work on a selected
research project
• under the guidance of a recognized
postgraduate teacher.
• The results of such work shall be
submitted in the form of a dissertation.
Aim of Dissertation
• To train a postgraduate student in research
methods and techniques.
• It includes
• identification of the problem,
• formulation of a hypothesis,
• review of literature,
• getting acquainted with recent advances,
• designing of a research study,
• collection of data,
• critical analysis, and
• comparison of results and drawing conclusions.
• Introduction
• Aims or Objectives of study
• Review of Literature
• Material and Methods
• Results
• Discussion
• Conclusion
• Summary
• References
• Tables
• Annexure
SUBMISSION OF DISSERTATION:
• Hard and soft copies of the dissertation to be
certified by the Guide, Head of the Department
and the Principal
• Should be submitted to the Register
(evaluation), RGUHS.
• Through the principal two months before the
final examination notified by RGUHS.
VIVA-VOCE EXAMINATION:
• The Viva-Voce examination shall aim at assessing
the depth of knowledge, logical reasoning,
confidence and oral communication skills.
• The Viva Voce examination shall be held after the
submission of dissertation.
• If any candidate fails to submit the dissertation on
or before the date prescribed, him/her Viva Voce
shall be conducted during the subsequent
examination which shall not be earlier than six
months from the date fixed in the first instance.
VIVA-VOCE EXAMINATION:
• Examiners:
• There shall be at least two examiners in each
branch / specialization
• out of them one shall be external examiner and
the other one shall be the internal examiner.
• The internal examiner ordinarily be the guide.
DISTRIBUTION OF MARKS FOR
M. PHARM PART-II EXAMINATION
• The dissertation viva voce shall be valued, by the
examiners together appointed by the university.
Total 200
marks
Dissertation-
150 marks
Viva Voce-50
marks
Scheme of evaluation of M. Pharm.
Dissertation
• The minimum marks for pass mark
• M. Pharm part II shall be
• 50% of the marks of dissertation and
• 50% of the marks in viva
and an aggregate of
• 100 marks out of 200 marks.
Minimum
Passing mark
M.Pharm Part-II
50% mark
Dissertation
(out of 150)
75/150
50% Mark
Viva
(out of 50)
25/50
100/150
Class
• shall be declared on the basis of the aggregate of
marks scored in M. Pharm Part I and part II as
follows:
• (1) 75% and above - Distinction
• (2) 60% & above but less than 75% - First class
• (3) 50% & above but less than 60% -Second class
Congratulations
Reference
• RGUHS Revised syllabus 2014
Thank You

More Related Content

What's hot

Approved regulatory bodies and agencies.
Approved regulatory bodies and agencies. Approved regulatory bodies and agencies.
Approved regulatory bodies and agencies.
Akshita Dholakiya
 
Supac
Supac Supac
Master formula record
Master formula recordMaster formula record
Master formula record
Doninder Hooda
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
Jafarali Masi
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
Suvarta Maru
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
Jafarali Masi
 
study design for bioavailability and bioequivalence
study design for bioavailability and bioequivalencestudy design for bioavailability and bioequivalence
study design for bioavailability and bioequivalence
Priya Rajput
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical product
Atul Bhombe
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
Namdeo Shinde
 
Generic drug product development
Generic drug product developmentGeneric drug product development
Generic drug product development
Bashant Kumar sah
 
Community Pharmacy by Dipali Trivedi
Community Pharmacy by Dipali TrivediCommunity Pharmacy by Dipali Trivedi
Community Pharmacy by Dipali Trivedi
DipaliTrivedi2
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
Dr Sukanta sen
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
Sulekha Rohilla
 
Multicomponant analysis
Multicomponant analysisMulticomponant analysis
Multicomponant analysis
Pinak patel
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
RAHUL PAL
 
Formulation and evaluation of tdds
Formulation and evaluation of tddsFormulation and evaluation of tdds
Formulation and evaluation of tdds
Pankaj Verma
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
Manish Rajput
 
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
regulatory requirements for drug approval ( IP-2  / UNIT -3 )regulatory requirements for drug approval ( IP-2  / UNIT -3 )
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
JAYACHANDRA AKUTHOTA
 

What's hot (20)

Approved regulatory bodies and agencies.
Approved regulatory bodies and agencies. Approved regulatory bodies and agencies.
Approved regulatory bodies and agencies.
 
Nda
NdaNda
Nda
 
Supac
Supac Supac
Supac
 
Hatch waxman act
Hatch waxman actHatch waxman act
Hatch waxman act
 
Master formula record
Master formula recordMaster formula record
Master formula record
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
 
study design for bioavailability and bioequivalence
study design for bioavailability and bioequivalencestudy design for bioavailability and bioequivalence
study design for bioavailability and bioequivalence
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical product
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
 
Generic drug product development
Generic drug product developmentGeneric drug product development
Generic drug product development
 
Community Pharmacy by Dipali Trivedi
Community Pharmacy by Dipali TrivediCommunity Pharmacy by Dipali Trivedi
Community Pharmacy by Dipali Trivedi
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Multicomponant analysis
Multicomponant analysisMulticomponant analysis
Multicomponant analysis
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
 
Formulation and evaluation of tdds
Formulation and evaluation of tddsFormulation and evaluation of tdds
Formulation and evaluation of tdds
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
 
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
regulatory requirements for drug approval ( IP-2  / UNIT -3 )regulatory requirements for drug approval ( IP-2  / UNIT -3 )
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
 

Viewers also liked

Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
Jing Zang
 
Dissertation Defense Presentation
Dissertation Defense PresentationDissertation Defense Presentation
Dissertation Defense Presentation
Brian Dorney
 
Oral Defense - 6-8-16
Oral Defense - 6-8-16Oral Defense - 6-8-16
Oral Defense - 6-8-16Jeff Ahrstrom
 
Ed s turner iii oral defense presentation - 18 feb 10
Ed s  turner iii   oral defense presentation - 18 feb 10Ed s  turner iii   oral defense presentation - 18 feb 10
Ed s turner iii oral defense presentation - 18 feb 10Dr. Ed S. Turner III
 
Example Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point SlideExample Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point Slide
Dr. Vince Bridges
 
Dissertation Defense Presentation
Dissertation Defense PresentationDissertation Defense Presentation
Dissertation Defense Presentation
Dr. Timothy Kelly
 
Presentation for Dissertation Proposal Defense
Presentation for Dissertation Proposal DefensePresentation for Dissertation Proposal Defense
Presentation for Dissertation Proposal Defense
andrearoofe
 
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
Dr. Ravi Sankar
 
Sampling of pharmaceuticals
Sampling  of pharmaceuticalsSampling  of pharmaceuticals
Sampling of pharmaceuticals
GMP EDUCATION : Not for Profit Organization
 
Sampling methods PPT
Sampling methods PPTSampling methods PPT
Sampling methods PPT
Vijay Mehta
 
Dissertation oral defense presentation
Dissertation   oral defense presentationDissertation   oral defense presentation
Dissertation oral defense presentationDr. Naomi Mangatu
 

Viewers also liked (12)

Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
Evaluation of Analgesic Activity of Some Polyherbal Extracts against Acetic A...
 
Dissertation Defense Presentation
Dissertation Defense PresentationDissertation Defense Presentation
Dissertation Defense Presentation
 
Oral Defense - 6-8-16
Oral Defense - 6-8-16Oral Defense - 6-8-16
Oral Defense - 6-8-16
 
Ed s turner iii oral defense presentation - 18 feb 10
Ed s  turner iii   oral defense presentation - 18 feb 10Ed s  turner iii   oral defense presentation - 18 feb 10
Ed s turner iii oral defense presentation - 18 feb 10
 
defense_2
defense_2defense_2
defense_2
 
Example Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point SlideExample Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point Slide
 
Dissertation Defense Presentation
Dissertation Defense PresentationDissertation Defense Presentation
Dissertation Defense Presentation
 
Presentation for Dissertation Proposal Defense
Presentation for Dissertation Proposal DefensePresentation for Dissertation Proposal Defense
Presentation for Dissertation Proposal Defense
 
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR
 
Sampling of pharmaceuticals
Sampling  of pharmaceuticalsSampling  of pharmaceuticals
Sampling of pharmaceuticals
 
Sampling methods PPT
Sampling methods PPTSampling methods PPT
Sampling methods PPT
 
Dissertation oral defense presentation
Dissertation   oral defense presentationDissertation   oral defense presentation
Dissertation oral defense presentation
 

Similar to Rguhs regulations and syllabus for m.pharm pharmaceutics

M Pharm Regulations 2020.pdf
M Pharm Regulations 2020.pdfM Pharm Regulations 2020.pdf
M Pharm Regulations 2020.pdf
geddamravikanth
 
Mba syllabus 2010_3
Mba syllabus 2010_3Mba syllabus 2010_3
Mba syllabus 2010_3josereddy
 
Osmania University Mba syllabus 2013
Osmania University Mba syllabus 2013Osmania University Mba syllabus 2013
Osmania University Mba syllabus 2013
Osmania University
 
BUSM Clinical Investigation Brochure
BUSM Clinical Investigation BrochureBUSM Clinical Investigation Brochure
BUSM Clinical Investigation Brochure
BU Clinical Research Program
 
Internal assessment & formative assessment
Internal assessment  & formative assessmentInternal assessment  & formative assessment
Internal assessment & formative assessment
MunmunDasSarkar
 
LLM Regulations
LLM RegulationsLLM Regulations
PCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientationPCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientation
Somu Chaudhari
 
The HDR Examination Process at MQ
The HDR Examination Process at MQThe HDR Examination Process at MQ
The HDR Examination Process at MQ
Merilyn Childs @ Macquarie University
 
bharathyar university msc microbiology syllabuss
bharathyar university msc microbiology syllabussbharathyar university msc microbiology syllabuss
bharathyar university msc microbiology syllabuss
Sridhar.p sri
 
Master of physiotherapy(m.p.t.) part i(semester i & ii)
Master of physiotherapy(m.p.t.) part i(semester i & ii)Master of physiotherapy(m.p.t.) part i(semester i & ii)
Master of physiotherapy(m.p.t.) part i(semester i & ii)BASIT Rehman
 
Bba cbcs-syllabus
Bba cbcs-syllabusBba cbcs-syllabus
Bba cbcs-syllabus
TocbmBangalore
 
Bba cbcs-syllabus
Bba cbcs-syllabusBba cbcs-syllabus
Bba cbcs-syllabus
ravalhimani
 
M.tech. cse csesy
M.tech.   cse csesyM.tech.   cse csesy
M.tech. cse csesyJampala Nag
 
Syllabus B.Pharm(Hons) NUB MANIK
Syllabus B.Pharm(Hons) NUB MANIKSyllabus B.Pharm(Hons) NUB MANIK
Syllabus B.Pharm(Hons) NUB MANIK
Imran Nur Manik
 
Update on Post-Graduate Medical Education Regulations, 2023.pptx
Update on Post-Graduate Medical Education Regulations, 2023.pptxUpdate on Post-Graduate Medical Education Regulations, 2023.pptx
Update on Post-Graduate Medical Education Regulations, 2023.pptx
MOPHCHOLAVANAHALLY
 
M.sc. nursing-syllabus 0108
M.sc. nursing-syllabus 0108M.sc. nursing-syllabus 0108
M.sc. nursing-syllabus 0108
KmShabanaAazmi
 
M.Sc.I Zoology Syllabus Credit system
M.Sc.I Zoology Syllabus Credit systemM.Sc.I Zoology Syllabus Credit system
Ph.d 2021 orientation
Ph.d 2021 orientationPh.d 2021 orientation
Ph.d 2021 orientation
Sumi Surendran S
 
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCIAssessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
Dr Girish B
 

Similar to Rguhs regulations and syllabus for m.pharm pharmaceutics (20)

M Pharm Regulations 2020.pdf
M Pharm Regulations 2020.pdfM Pharm Regulations 2020.pdf
M Pharm Regulations 2020.pdf
 
Mba syllabus 2010_3
Mba syllabus 2010_3Mba syllabus 2010_3
Mba syllabus 2010_3
 
Osmania University Mba syllabus 2013
Osmania University Mba syllabus 2013Osmania University Mba syllabus 2013
Osmania University Mba syllabus 2013
 
BUSM Clinical Investigation Brochure
BUSM Clinical Investigation BrochureBUSM Clinical Investigation Brochure
BUSM Clinical Investigation Brochure
 
Internal assessment & formative assessment
Internal assessment  & formative assessmentInternal assessment  & formative assessment
Internal assessment & formative assessment
 
LLM Regulations
LLM RegulationsLLM Regulations
LLM Regulations
 
PCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientationPCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientation
 
The HDR Examination Process at MQ
The HDR Examination Process at MQThe HDR Examination Process at MQ
The HDR Examination Process at MQ
 
bharathyar university msc microbiology syllabuss
bharathyar university msc microbiology syllabussbharathyar university msc microbiology syllabuss
bharathyar university msc microbiology syllabuss
 
Master of physiotherapy(m.p.t.) part i(semester i & ii)
Master of physiotherapy(m.p.t.) part i(semester i & ii)Master of physiotherapy(m.p.t.) part i(semester i & ii)
Master of physiotherapy(m.p.t.) part i(semester i & ii)
 
Bba cbcs-syllabus
Bba cbcs-syllabusBba cbcs-syllabus
Bba cbcs-syllabus
 
Bba cbcs-syllabus
Bba cbcs-syllabusBba cbcs-syllabus
Bba cbcs-syllabus
 
M.tech. cse csesy
M.tech.   cse csesyM.tech.   cse csesy
M.tech. cse csesy
 
Syllabus B.Pharm(Hons) NUB MANIK
Syllabus B.Pharm(Hons) NUB MANIKSyllabus B.Pharm(Hons) NUB MANIK
Syllabus B.Pharm(Hons) NUB MANIK
 
B pharm detail syllabus1
B pharm detail syllabus1B pharm detail syllabus1
B pharm detail syllabus1
 
Update on Post-Graduate Medical Education Regulations, 2023.pptx
Update on Post-Graduate Medical Education Regulations, 2023.pptxUpdate on Post-Graduate Medical Education Regulations, 2023.pptx
Update on Post-Graduate Medical Education Regulations, 2023.pptx
 
M.sc. nursing-syllabus 0108
M.sc. nursing-syllabus 0108M.sc. nursing-syllabus 0108
M.sc. nursing-syllabus 0108
 
M.Sc.I Zoology Syllabus Credit system
M.Sc.I Zoology Syllabus Credit systemM.Sc.I Zoology Syllabus Credit system
M.Sc.I Zoology Syllabus Credit system
 
Ph.d 2021 orientation
Ph.d 2021 orientationPh.d 2021 orientation
Ph.d 2021 orientation
 
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCIAssessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
Assessment in CBME Competency Based Medical Education Dr Girish .B CISP 2 MCI
 

Recently uploaded

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 

Recently uploaded (20)

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 

Rguhs regulations and syllabus for m.pharm pharmaceutics

  • 1. Regulations for M.Pharm Degree Academic Year 2015-16 Rajiv Gandhi University of Health Sciences, Karnataka Presented By G.Parthasarathy Associate Professor and Head, Department of Pharmaceutics, R R College of Pharmacy, Bangalore
  • 2. A Warm Welcome to the fresh students of B.Pharm , Pharm D and M.Pharm on behalf of The Management, Teaching and Non- teaching Faculties of RR College of Pharmacy
  • 3. GOAL of M.Pharm curriculum To produce a competent Industrial Pharmacist.
  • 4. OBJECTIVE: • Understanding of the concept and design of various pharmaceutical dosage forms • The ability to formulate and evaluate various dosage forms • The ability to work independently and as a member of the team • The ability to plan his / her work for efficient use of time and resources • The ability to identify the cause and to solve the problem • The ability to think and evaluate scientifically and critically
  • 5. Master of Pharmacy (Pharmaceutics) •Duration of the course 24Months Only
  • 6. Duration and Course Pattern The study of M. Pharm course shall be of annual system, that include M. Pharm part-I, for twelve months M. Pharm part-II of twelve months duration. At the end of M. Pharm part-I, there shall be an university examination of M. Pharm Part-I. At the end of M. Pharm Part-II, the candidate shall submit a dissertation on the topic approved by the university.
  • 7. Attendance and Monitoring Process of Studies • A candidate pursuing M. Pharm course shall study in the concerned department as full time student. • Every student shall attend symposia, seminars, conferences, journal review meetings and lectures during each year as prescribed by the department/college/university and not absent him/her without valid reasons. • Candidate who has put in a minimum of 80% of attendance in theory and practical assignments separately shall be permitted to appear for M. Pharm part-I examination. • Candidate who has put in a minimum of 80% of attendance in M. Pharm part-II shall only be eligible to submit the dissertation. • Any student who fails to complete the course in the manner stated above shall not be permitted to appear for the University examinations.
  • 9. Monitoring Progress of Studies • Every candidate shall maintain a work diary and record of his/her participation in the training programmes conducted by the department such as journal reviews, seminars, etc. • The work diary shall be scrutinized and certified by the Head of the Department and Head of the Institution, and presented in the University practical examination. • Special circulation may be made to all faculties about the presentations given by the candidate.
  • 10. Subjects (M.Pharm Pharmaceutics) • Paper I: Modern Pharmaceutical Analysis • Paper II: Preformulation and Production Management • Paper III: Biopharmaceutics and Pharmacokinetics • Paper IV: Advances in Drug Delivery Systems
  • 11. Teaching/ Learning Activities:  Journal Club: weekly, Journal club meetings to be held to discuss the recent development in the subject published in the national and international journals.  Seminars: Seminars (5-6 in a year) will be arranged from experts in the field.  Industrial visits: Visits to pharmaceutical industries to understand shop floor activities.  Conferences and meetings: Staff and students will be encouraged to participate in seminars, workshops and conferences in the area of this subject.
  • 12. EXAMINATION • There shall be an examination for M. Pharm part-I at the end of on academic year. • For M. pharm part-II, the examination shall be an evaluation of dissertation and Viva-Voce at the end of twelve months (one Year) after commencement of M. Pharm Part-II course.
  • 13. SCHEME OF EXAMINATION • Sessional Examination: ▫ There shall be minimum of two sessional examinations in each subject ▫ conducted by the colleges for both in theory and in practical. ▫ The sessional marks shall be awarded out of a maximum of 50 for theory and practical.
  • 14. Sessional Examination Theory Practical a) Written examination (average of two) 30 marks a) Practical Examination (average of two) 30 marks b) Seminar 20 Marks b) Lab work 20 marks Total Marks 50 marks Total Marks 50 Marks
  • 15. Synopsis • A candidate should submit synopsis of Research work • To the Registrar, RGUHS of the intended project work • Through the guide, HOD and Head of the institutions • Not later than nine months from the date of admission to M. Pharm part I on or before the date specified by RGUHS.
  • 16. Online Registration of Subject for Synopsis • All M.Pharm Part-I candidates should register a topic for their research work in the form of synopsis in RGUHS format. • Synopsis should be approved by their Guide, HOD and Head of the institution before Online submission. • Later, A detailed Review report and status of registration will be communicated to the students
  • 17. University Theory Examination ( M. Pharm Part-I) • There shall be two university examinations annually conducted at an interval of not less than four months. • There shall be four theory papers in the university examination. • Each theory paper shall be of 3 hours duration carrying 100 marks each. • In each paper, there shall be two long essay questions of 20 marks • Five short essay questions of ten marks • Two short notes of five marks
  • 18. Theory Subjects Duration of Exam (Hours) Maximum marks for written exam Sessional maximum marks Total Paper I: Modern Pharmaceutical Analysis 3 100 50 150 Paper II : Preformulation and Production Management 3 100 50 150 Paper III : Biopharmaceutics and Pharmacokinetics 3 100 50 150 Paper IV : Advances in Drug Delivery Systems 3 100 50 150 Total 600
  • 19. University Practical Exam ( M. Pharm Part-I) • There shall be four practical examinations in all subjects. • The duration of each practical examination is of six hours • It will be conducted for 100 marks each.
  • 20. Practical Subjects Duration of paper (Hours) Maximum marks for written exam Sessional maximum marks Total Paper I: Modern Pharmaceutical Analysis 6 100 50 150 Paper II : Preformulation and Production Management 6 100 50 150 Paper III : Biopharmaceutics and Pharmacokinetics 6 100 50 150 Paper IV : Advances in Drug Delivery Systems 6 100 50 150 Total 600
  • 21. Criteria for Pass (M. Pharm Part-I) • A candidate who secures 50% of marks in each subject in theory and in practical separately including sessional marks and university examination marks together shall be declared to have passed in M. Pharm part-I examination • The candidate must secure a minimum of 40% marks (excluding sessionals) in theory & practical separately.
  • 22. Minimum Passing mark 50% (Written + Sessional IA) (100+50) 75/150 Written Exam (Theory/Practical 40% Compulsory 40/100
  • 23. • Candidate, who fails in theory or practical exam in a subject, shall appear for both theory and practical in the subsequent examination in a subject. • Candidates permitted to take re-sessional examination after the announcement of results only once
  • 25. Dissertation • Every candidate pursuing M. Pham course is required to work on a selected research project • under the guidance of a recognized postgraduate teacher. • The results of such work shall be submitted in the form of a dissertation.
  • 26. Aim of Dissertation • To train a postgraduate student in research methods and techniques. • It includes • identification of the problem, • formulation of a hypothesis, • review of literature, • getting acquainted with recent advances, • designing of a research study, • collection of data, • critical analysis, and • comparison of results and drawing conclusions.
  • 27. • Introduction • Aims or Objectives of study • Review of Literature • Material and Methods • Results • Discussion • Conclusion • Summary • References • Tables • Annexure
  • 28. SUBMISSION OF DISSERTATION: • Hard and soft copies of the dissertation to be certified by the Guide, Head of the Department and the Principal • Should be submitted to the Register (evaluation), RGUHS. • Through the principal two months before the final examination notified by RGUHS.
  • 29. VIVA-VOCE EXAMINATION: • The Viva-Voce examination shall aim at assessing the depth of knowledge, logical reasoning, confidence and oral communication skills. • The Viva Voce examination shall be held after the submission of dissertation. • If any candidate fails to submit the dissertation on or before the date prescribed, him/her Viva Voce shall be conducted during the subsequent examination which shall not be earlier than six months from the date fixed in the first instance.
  • 30. VIVA-VOCE EXAMINATION: • Examiners: • There shall be at least two examiners in each branch / specialization • out of them one shall be external examiner and the other one shall be the internal examiner. • The internal examiner ordinarily be the guide.
  • 31. DISTRIBUTION OF MARKS FOR M. PHARM PART-II EXAMINATION • The dissertation viva voce shall be valued, by the examiners together appointed by the university. Total 200 marks Dissertation- 150 marks Viva Voce-50 marks
  • 32. Scheme of evaluation of M. Pharm. Dissertation • The minimum marks for pass mark • M. Pharm part II shall be • 50% of the marks of dissertation and • 50% of the marks in viva and an aggregate of • 100 marks out of 200 marks.
  • 33. Minimum Passing mark M.Pharm Part-II 50% mark Dissertation (out of 150) 75/150 50% Mark Viva (out of 50) 25/50 100/150
  • 34. Class • shall be declared on the basis of the aggregate of marks scored in M. Pharm Part I and part II as follows: • (1) 75% and above - Distinction • (2) 60% & above but less than 75% - First class • (3) 50% & above but less than 60% -Second class
  • 36. Reference • RGUHS Revised syllabus 2014 Thank You